|
| 37948006 | Comparing the Efficacy and Safety of Galcanezumab Versus Rimegepant for Prevention of Episodic Migraine: Results from a Randomized, Controlled Clinical Trial. | Neurol Ther | 2024 |
| 36656082 | Pyroptosis in neutrophils: Multimodal integration of inflammasome and regulated cell death signaling pathways. | Immunol Rev | 2023 |
| 37060806 | Immunity to pathogenic fungi in the eye. | Semin Immunol | 2023 |
| 36698021 | CCR2-positive monocytes contribute to the pathogenesis of early diabetic retinopathy in mice. | Diabetologia | 2023 |
| 34995333 | Control of β-glucan exposure by the endo-1,3-glucanase Eng1 in Candida albicans modulates virulence. | PLoS Pathog | 2022 |
| 35851538 | Differential Roles for IL-1α and IL-1β in Pseudomonas aeruginosa Corneal Infection. | J Immunol | 2022 |
| 36111429 | A phase IV clinical trial of gastrointestinal motility in adult patients with migraine before and after initiation of a calcitonin gene-related peptide ligand (galcanezumab) or receptor (erenumab) antagonist. | Headache | 2022 |
| 35076091 | Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study. | Headache | 2022 |
| 33333123 | OVOL1 Regulates Psoriasis-Like Skin Inflammation and Epidermal Hyperplasia. | J Invest Dermatol | 2021 |
| 33549036 | Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine. | J Headache Pain | 2021 |
| 33765912 | Early onset of effect following galcanezumab treatment in patients with previous preventive medication failures. | J Headache Pain | 2021 |
| 33544305 | Onset, Maintenance, and Cessation of Effect of Galcanezumab for Prevention of Migraine: A Narrative Review of Three Randomized Placebo-Controlled Trials. | Adv Ther | 2021 |
| 33771951 | American Academy of Optometry Microbial Keratitis Think Tank. | Optom Vis Sci | 2021 |
| 34454420 | A close association of freedom from pain, migraine-related functional disability, and other outcomes: results of a post hoc analysis of randomized lasmiditan studies SAMURAI and SPARTAN. | J Headache Pain | 2021 |
| 34419783 | Pathogenic Aspergillus and Fusarium as important causes of blinding corneal infections - the role of neutrophils in fungal killing, tissue damage and cytokine production. | Curr Opin Microbiol | 2021 |
| 34445967 | Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine. | J Headache Pain | 2021 |
| 33994111 | The impact of age-related hypomethylated DNA on immune signaling upon cellular demise. | Trends Immunol | 2021 |
| 34010648 | β-Glucan-stimulated neutrophil secretion of IL-1α is independent of GSDMD and mediated through extracellular vesicles. | Cell Rep | 2021 |
| 33950375 | Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine: A Post Hoc Analysis. | Adv Ther | 2021 |
| 33143451 | Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine. | Cephalalgia | 2021 |
| 31562697 | Delineating the role of MITF isoforms in pigmentation and tissue homeostasis. | Pigment Cell Melanoma Res | 2020 |
| 35019543 | Synergistic Antimicrobial Activity of a Nanopillar Surface on a Chitosan Hydrogel. | ACS Appl Bio Mater | 2020 |
| 31871024 | Tuning Subunit Vaccines with Novel TLR Triagonist Adjuvants to Generate Protective Immune Responses against <i>Coxiella burnetii</i>. | J Immunol | 2020 |
| 32005944 | The genome of opportunistic fungal pathogen Fusarium oxysporum carries a unique set of lineage-specific chromosomes. | Commun Biol | 2020 |
| 33063862 | Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double-Blind, Placebo-Controlled REGAIN, and Pooled EVOLVE-1 and EVOLVE-2 Studies. | Headache | 2020 |
| 32449213 | Effects of lasmiditan on simulated driving performance: Results of two randomized, blinded, crossover studies with placebo and active controls. | Hum Psychopharmacol | 2020 |
| 32340471 | Assessment of immunogenicity from galcanezumab phase 3 trials in patients with episodic or chronic migraine. | Cephalalgia | 2020 |
| 32117802 | What Are the Functions of Chitin Deacetylases in <i>Aspergillus fumigatus</i>? | Front Cell Infect Microbiol | 2020 |
| 32371889 | N-GSDMD trafficking to neutrophil organelles facilitates IL-1β release independently of plasma membrane pores and pyroptosis. | Nat Commun | 2020 |
| 32319039 | Efficacy and Safety of Galcanezumab for the Preventive Treatment of Migraine: A Narrative Review. | Adv Ther | 2020 |
| 31595600 | Positive response to galcanezumab following treatment failure to onabotulinumtoxinA in patients with migraine: post hoc analyses of three randomized double-blind studies. | Eur J Neurol | 2020 |
| 30462830 | Analysis of Initial Nonresponders to Galcanezumab in Patients With Episodic or Chronic Migraine: Results From the EVOLVE-1, EVOLVE-2, and REGAIN Randomized, Double-Blind, Placebo-Controlled Studies. | Headache | 2019 |
| 35030760 | Biomimetic Nanopillared Surfaces Inhibit Drug Resistant Filamentous Fungal Growth. | ACS Appl Bio Mater | 2019 |
| 31819296 | Infectious corneal ulceration: a proposal for neglected tropical disease status. | Bull World Health Organ | 2019 |
| 31433669 | Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study). | Cephalalgia | 2019 |
| 31291578 | EphA2 Is a Neutrophil Receptor for Candida albicans that Stimulates Antifungal Activity during Oropharyngeal Infection. | Cell Rep | 2019 |
| 31367214 | NLRP3, NLRP12, and IFI16 Inflammasomes Induction and Caspase-1 Activation Triggered by Virulent HSV-1 Strains Are Associated With Severe Corneal Inflammatory Herpetic Disease. | Front Immunol | 2019 |
| 31116437 | Breaching bacterial biofilm with neutrophil α-mannosidase. | J Leukoc Biol | 2019 |
| 30973202 | Response to Misused and Misleading: 100% Response Rate to Galcanezumab in Patients With Episodic Migraine. | Headache | 2019 |
| 30903663 | Aspergillus fumigatus corneal infection is regulated by chitin synthases and by neutrophil-derived acidic mammalian chitinase. | Eur J Immunol | 2019 |
| 31104507 | Efficacy of galcanezumab in patients with chronic migraine and a history of preventive treatment failure. | Cephalalgia | 2019 |
| 29324230 | Neutrophils Cause an Intravascular Traffic Jam. | Cell Host Microbe | 2018 |
| 29896200 | Protein Deiminase 4 and CR3 Regulate <i>Aspergillus fumigatus</i> and β-Glucan-Induced Neutrophil Extracellular Trap Formation, but Hyphal Killing Is Dependent Only on CR3. | Front Immunol | 2018 |
| 30426478 | Basic Considerations for the Use of Monoclonal Antibodies in Migraine. | Headache | 2018 |
| 30266768 | Neutrophil Caspase-11 Is Required for Cleavage of Caspase-1 and Secretion of IL-1β in <i>Aspergillus fumigatus</i> Infection. | J Immunol | 2018 |
| 30341990 | 100% Response Rate to Galcanezumab in Patients With Episodic Migraine: A Post Hoc Analysis of the Results From Phase 3, Randomized, Double-Blind, Placebo-Controlled EVOLVE-1 and EVOLVE-2 Studies. | Headache | 2018 |
| 30588331 | Sustained release of decorin to the surface of the eye enables scarless corneal regeneration. | NPJ Regen Med | 2018 |
| 29625485 | Atovaquone Impairs Growth of Aspergillus and Fusarium Keratitis Isolates by Modulating Mitochondrial Function and Zinc Homeostasis. | Invest Ophthalmol Vis Sci | 2018 |
| 27858252 | Polymeric Nanofiber/Antifungal Formulations Using a Novel Co-extrusion Approach. | AAPS PharmSciTech | 2017 |
| 28494242 | Pseudomonas aeruginosa Effector ExoS Inhibits ROS Production in Human Neutrophils. | Cell Host Microbe | 2017 |